M-2000, as a new anti-inflammatory molecule in treatment of experimental nephrosis

Immunopharmacology and Immunotoxicology

Volumn 26, Issue 4, 2004, Pages 611-619

  Mirshafiey, Abbas ^a   Rehm, Bernd H A ^b   Sahmani, Ahmad Ali ^a   Naji, Aboulghasem ^a   Razavi, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Nephrosis treatment; Nephrotic syndrome; Proteinuria

Indexed keywords

ANTIINFLAMMATORY AGENT; CHOLESTEROL; CREATININE; DOXORUBICIN; INTERLEUKIN 6; M 2000; PIROXICAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENCY; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY TUBULE; LEUKOCYTE ACTIVATION; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD UREA NITROGEN; CREATININE; DISEASE MODELS, ANIMAL; FEMALE; HYDROCARBONS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; KIDNEY; KIDNEY FUNCTION TESTS; LIPIDS; NEPHROTIC SYNDROME; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; GLOMERULUS;

EID: 11344259249     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-200042362     Document Type: Article

References (25)

1. Cunard, R.; Kelly, C.J. Immune-mediated renal disease. J. Allergy Clin. Immunol. 2003, 111, S637-S643.
2. Bustos, C.; Gonzales-Cuadrado, S.; Ruiz-Ortega, M.; Gomes-Guerrero, C.; Gonzalez, E.; Plaza, J.J.; Egido, J. Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis. Clin. Exp. Immunol. 1995, 102, 608-613.
3. Kanwar, Y.S.; Liu, Z.Z.; Kashihara, N. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin. Nephrol. 1991, 11, 390-413.
4. Nolasco, F.; Cameron, J.S.; Heywood, E.F.; Hicks, J.; Ogg, C.; Williams, D.G. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. 1986, 29, 1215-1223.
5. Bertani, T.; Rocchi, G.; Sacchi, G.; Mecca, G.; Remuzzi, G. Adriamycin-induced glomerulosclerosis in the rat. Am. J. Kidney Dis. 1986, 7, 12-19.
6. Tsuchida, T.; Eguchi, N.; Eguchi, Y.; Numabe, A.; Nakajima, H.; Oda, H.; Seiki, K.; Hakamada-Taguchi, R.; Urade, Y.; Uehara, Y. Lipocalin-type prostaglandin D synthase in urine in adriamycin-induced nephropathy of mice. Nephron. Physiol. 2004, 96, 42-51.
7. Nakayama, K.; Natori, Y.; Sato, T.; Kimura, T.; Sugiura, A.; Sato, H.; Saito, T.; Ito, S.; Natori, Y. Altered expression of NDST-1 messenger RNA in Puromycin aminonucleoside nephrosis. J. Lab. Clin. Med. 2004, 143, 106-114.
8. Bertani, T.; Cutillo, F.; Zoja, C.; Broggini, M.; Remuzzi, G. Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int. 1986, 30, 488-496.
9. Okuda, S.; Oh, Y.; Tsuruda, H.; Onoyama, K.; Fujimi, S.; Fujishima, M. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int. 1986, 29, 502-510.
10. Javaid, B.; Olson, J.L.; Meyer, T.W. Glomerular injury and tubular loss in adriamycin nephrosis. J. Am. Soc. Nephrol. 2001, 12, 1391-1400.
11. Zima, T.; Tesar, V.; Crkovska, J.; Stejskalova, A.; Platenik, J.; Teminova, J.; Nemecek, K.; Janebova, M.; Stipek, S. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats. Nephrol. Dial. Transplant. 1998, 13, 1975-1979.
12. Bousnes, R.W.; Taussky, A.A. The calorimetric determination of creatinine by the Jaffe reaction. J. Biol. Chem. 1945, 158, 581-591.
13. Veniamin, M.P.; Vakirtzi-Lemonias, C. Chemical basis of the carbamidodiacetyl micromethod for estimation of urea, citrulline and carbamyl derivatives. Clin. Chem. 1970, 16, 3-6.
14. Remuzzi, G.; Zoja, C.; Remuzzi, A. Low-protein diet prevents glomerular damage in adriamycin-treated rats. Kidney Int. 1985, 28, 21-27.
15. Okasora, T.; Takikawa, T.; Utsunomiya, Y. Suppressive effect of superoxide dismutase on adriamycin nephropathy. Nephron 1992, 60, 199-203.
16. Dogra, G.K.; Herrmann, S.; Irish, A.B.; Thomas, M.A.; Watts, G.F. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol. Dial. Transplant. 2002, 17, 2220-2225.
17. Fukatsu, A.; Matsuo, S.; Tamai, H.; Sakamoto, N.; Matsuda, T.; Hirano, T. Distribution of interleukin-6 in normal and diseased human kidney. Lab. Invest. 1991, 65, 61-66.
18. Vaziri, N.D.; Liang, K.H. Down-regulation of hepatic LDL receptor expression in experimental nephrosis. Kidney Int. 1996, 50, 887-893.
19. Pesek-Diamond, I.; Ding, G.; Frye, J.; Diamond, J.R. Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. Am. J. Physiol. 1992, 263, F776-F783.
20. Stollbergen, C.; Finsterer, J. Side effects of conventional nonsteroidal antiinflammatory drugs and celecoxib: more similarities than differences. South Med. J. 2004, 97, 209.
21. Fogo, A.B. Acute interstitial nephritis and minimal change disease lesion, caused by NSAIDs injury. Am. J. Kidney Dis. 2003, 42, A41-E1.
22. Reinhold, S.W.; Fischereder, M.; Riegger, G.A.; Kramer, B.K. Acute renal failure after administration of a single dose of a highly selective COX-2 inhibitor. Clin. Nephrol. 2003, 60, 295-296.
23. Basivireddy, J.; Jacob, M.; Pulimood, A.B.; Balasubramanian, K.A. Indomethacin-induced renal damage: role of oxygen free radicals. Biochem. Pharmacol. 2004, 67, 587-599.
24. Perazella, M.A. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am. J. Med. Sci. 2003, 325, 349-362.
25. Kaiser, A. Diclofenac caused renal insufficiency. A case illustrating the necessity of pharmaceutical intervention and care. Med. Monatsschr. Pharm. 2003, 26, 384-388.